Skip to content
10-Q

Quarterly Report

AARDVARK THERAPEUTICS, INC. AARD

0000950170-25-108116

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 21.7M sh
Shares Diluted Q2 2025 · Jun 30, 2025 21.69M sh
Shares Diluted Q2 2025 · Jun 30, 2025 17.47M sh
Shares Diluted Q2 2025 · Jun 30, 2024 3.97M sh
Shares Diluted Q2 2025 · Jun 30, 2024 3.97M sh
Capex Q2 2025 · Jun 30, 2025 $91K
Capex Q2 2025 · Jun 30, 2024 $98K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$21.23M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$6.41M
Short Term Investments Q2 2025 · Jun 30, 2025 $115.82M
Short Term Investments Q2 2025 · Dec 31, 2024 $12.02M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $26M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $61.64M
Stockholders Equity Q2 2025 · Jun 30, 2025 $136.93M
Stockholders Equity Q2 2025 · Mar 31, 2025 $150.69M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$54.64M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$42.31M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$36.91M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$34.8M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.31M
Current Liabilities Q2 2025 · Dec 31, 2024 $4.93M
Total Liabilities Q2 2025 · Jun 30, 2025 $10.55M
Total Liabilities Q2 2025 · Dec 31, 2024 $5.39M
Current Assets Q2 2025 · Jun 30, 2025 $144.77M
Current Assets Q2 2025 · Dec 31, 2024 $74.14M
Total Assets Q2 2025 · Jun 30, 2025 $147.48M
Total Assets Q2 2025 · Dec 31, 2024 $77.51M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.66
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.36
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.37
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.92
Eps Basic Q2 2025 · Jun 30, 2025 −$0.66
Eps Basic Q2 2025 · Jun 30, 2025 −$1.36
Eps Basic Q2 2025 · Jun 30, 2024 −$1.37
Eps Basic Q2 2025 · Jun 30, 2024 −$1.92
Sga Expense Q2 2025 · Jun 30, 2025 $2.7M
Sga Expense Q2 2025 · Jun 30, 2025 $5.42M
Sga Expense Q2 2025 · Jun 30, 2024 $2.03M
Sga Expense Q2 2025 · Jun 30, 2024 $2.89M
Rd Expense Q2 2025 · Jun 30, 2025 $13.15M
Rd Expense Q2 2025 · Jun 30, 2025 $20.9M
Rd Expense Q2 2025 · Jun 30, 2024 $4.03M
Rd Expense Q2 2025 · Jun 30, 2024 $5.24M
Net Income Q2 2025 · Jun 30, 2025 −$14.37M
Net Income Q2 2025 · Jun 30, 2025 −$23.68M
Net Income Q2 2025 · Jun 30, 2024 −$5.45M
Net Income Q2 2025 · Jun 30, 2024 −$7.63M
Operating Income Q2 2025 · Jun 30, 2025 −$15.85M
Operating Income Q2 2025 · Jun 30, 2025 −$26.32M
Operating Income Q2 2025 · Jun 30, 2024 −$6.07M
Operating Income Q2 2025 · Jun 30, 2024 −$8.24M
Revenue Q2 2025 · Jun 30, 2025 $0